Lv2
190 积分 2021-07-07 加入
以泽布替尼为基础的桥接方案在CAR-T细胞治疗复发难治弥漫大B细胞淋巴瘤中的临床安全性及疗效分析
17小时前
已完结
Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
18小时前
已完结
弥漫大B细胞淋巴瘤患者继发中枢神经系统侵犯风险评估和预防策略的研究现状
20小时前
已完结
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
1天前
已完结
Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice
1天前
已完结
Zanubrutinib Plus Rituximab in Older Unfit or Frail Previously Untreated Diffuse Large B-Cell Lymphoma: A Prospective Study Based on Comprehensive Geriatric Assessment
1天前
求助中
Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
3天前
已完结
The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation
3天前
已完结
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib
3天前
已完结
Advances in the treatment of mantle cell lymphoma with BTK inhibitors
3天前
已完结
皖公网安备34019202002308
